Bersacapavir (JNJ-56136379) is a novel in vitro modulator of hepatitis B virus capsid assembly that inhibits HBV replication.Bersacapavir is metabolized by cytochrome P450 (CYP) 3A and can be used to study Bersacapavir infection.
Molecular Weight:
418.37
Purity:
98.53%
CAS Number:
[1638266-40-6]
Formula:
C16H14F4N4O3S
Target:
HBV
T9769
T9769
* VAT and and shipping costs not included. Errors and price changes excepted